Onsun Nahide, Kaya Gökhan, Işık Bengisu Güçkan, Güneş Begüm
Department of Dermatology and Venereology, Bezmialem Vakif University, Istanbul, Turkey.
Health Promot Perspect. 2021 May 19;11(2):261-262. doi: 10.34172/hpp.2021.32. eCollection 2021.
CoronoVac is a non-viable vaccine for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). Nowadays, there has been vaccination program for at-risk groups and older adults in Turkey. We here present 72-year-old male psoriasis patient who developed generalized pustular psoriasis flare after administration of CoronoVac. The COVID-PCR test was negative and investigations for flare etiology were all normal. He was first (to the best of our knowledge) psoriasis patient who developed an erythrodermic flare after the first dose of CoronaVac vaccine.
科兴新冠疫苗是一种针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的灭活疫苗。如今，土耳其已为高危人群和老年人开展了疫苗接种计划。我们在此报告一名72岁的男性银屑病患者，他在接种科兴新冠疫苗后出现了泛发性脓疱型银屑病发作。新冠病毒聚合酶链式反应（COVID-PCR）检测呈阴性，对发作病因的检查均正常。据我们所知，他是首例在接种第一剂科兴新冠疫苗后出现红皮病型发作的银屑病患者。
